• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过带有屏蔽小核苷酸的遗传条形码对体内人 CAR T 细胞的命运进行多重转录组谱分析。

Multiplexed transcriptomic profiling of the fate of human CAR T cells in vivo via genetic barcoding with shielded small nucleotides.

机构信息

Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

出版信息

Nat Biomed Eng. 2023 Sep;7(9):1170-1187. doi: 10.1038/s41551-023-01085-3. Epub 2023 Aug 31.

DOI:10.1038/s41551-023-01085-3
PMID:37652986
Abstract

The design of chimeric antigen receptor (CAR) T cells would benefit from knowledge of the fate of the cells in vivo. This requires the permanent labelling of CAR T cell products and their pooling in the same microenvironment. Here, we report a cell-barcoding method for the multiplexed longitudinal profiling of cells in vivo using single-cell RNA sequencing (scRNA-seq). The method, which we named shielded-small-nucleotide-based scRNA-seq (SSN-seq), is compatible with both 3' and 5' single-cell profiling, and enables the recording of cell identity, from cell infusion to isolation, by leveraging the ubiquitous Pol III U6 promoters to robustly express small-RNA barcodes modified with direct-capture sequences. By using SSN-seq to track the dynamics of the states of CAR T cells in a tumour-rechallenge mouse model of leukaemia, we found that a combination of cytokines and small-molecule inhibitors that are used in the ex vivo manufacturing of CAR T cells promotes the in vivo expansion of persistent populations of CD4 memory T cells. By facilitating the probing of cell-state dynamics in vivo, SSN-seq may aid the development of adoptive cell therapies.

摘要

嵌合抗原受体 (CAR) T 细胞的设计将受益于对体内细胞命运的了解。这需要对 CAR T 细胞产品进行永久标记,并将其汇集在相同的微环境中。在这里,我们报告了一种用于使用单细胞 RNA 测序 (scRNA-seq) 对体内细胞进行多路纵向分析的细胞条形码方法。该方法我们称之为屏蔽的基于小核苷酸的 scRNA-seq (SSN-seq),与 3' 和 5' 单细胞分析兼容,并通过利用普遍存在的 Pol III U6 启动子来稳健表达带有直接捕获序列修饰的小 RNA 条形码,从而能够记录从细胞输注到分离的细胞身份。通过使用 SSN-seq 来跟踪白血病肿瘤再挑战小鼠模型中 CAR T 细胞状态的动态,我们发现,在体外制造 CAR T 细胞中使用的细胞因子和小分子抑制剂的组合促进了持久的 CD4 记忆 T 细胞群体在体内的扩增。通过促进体内细胞状态动力学的探测,SSN-seq 可能有助于过继细胞疗法的发展。

相似文献

1
Multiplexed transcriptomic profiling of the fate of human CAR T cells in vivo via genetic barcoding with shielded small nucleotides.通过带有屏蔽小核苷酸的遗传条形码对体内人 CAR T 细胞的命运进行多重转录组谱分析。
Nat Biomed Eng. 2023 Sep;7(9):1170-1187. doi: 10.1038/s41551-023-01085-3. Epub 2023 Aug 31.
2
Enriching and Characterizing T Cell Repertoires from 3' Barcoded Single-Cell Whole Transcriptome Amplification Products.从 3' 条形码单细胞全转录组扩增产物中丰富和描述 T 细胞受体库。
Methods Mol Biol. 2022;2574:159-182. doi: 10.1007/978-1-0716-2712-9_7.
3
Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies.利用单细胞测序技术进行嵌合抗原受体 T 细胞疗法。
Trends Biotechnol. 2021 Dec;39(12):1308-1320. doi: 10.1016/j.tibtech.2021.03.005. Epub 2021 Apr 5.
4
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.单细胞多组学解析靶向 CD19 的 CAR T 细胞的基础和抗原特异性激活状态。
J Immunother Cancer. 2021 May;9(5). doi: 10.1136/jitc-2020-002328.
5
Biomaterials in Chimeric Antigen Receptor T-Cell Process Development.嵌合抗原受体T细胞工艺开发中的生物材料
Acc Chem Res. 2020 Sep 15;53(9):1724-1738. doi: 10.1021/acs.accounts.0c00335. Epub 2020 Aug 6.
6
Multifunctional mRNA-Based CAR T Cells Display Promising Antitumor Activity Against Glioblastoma.多功能基于 mRNA 的 CAR T 细胞对胶质母细胞瘤显示出有前景的抗肿瘤活性。
Clin Cancer Res. 2022 Nov 1;28(21):4747-4756. doi: 10.1158/1078-0432.CCR-21-4384.
7
Single-cell multiplexed cytokine profiling of CD19 CAR-T cells reveals a diverse landscape of polyfunctional antigen-specific response.单细胞多重细胞因子分析 CD19 CAR-T 细胞揭示了多样化的多反应性抗原特异性反应景观。
J Immunother Cancer. 2017 Nov 21;5(1):85. doi: 10.1186/s40425-017-0293-7.
8
Revealing the heterogeneity of CD4 T cells through single-cell transcriptomics.通过单细胞转录组学揭示CD4 T细胞的异质性。
J Allergy Clin Immunol. 2022 Oct;150(4):748-755. doi: 10.1016/j.jaci.2022.08.010.
9
Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured electroporation or lentiviral transfection.电穿孔或慢病毒转染制造的嵌合抗原受体 T 淋巴细胞的表型和转录组特征的差异。
Front Immunol. 2023 May 9;14:1068625. doi: 10.3389/fimmu.2023.1068625. eCollection 2023.
10
In Vivo Generation of CAR T Cells Selectively in Human CD4 Lymphocytes.在人 CD4 淋巴细胞中选择性生成嵌合抗原受体 T 细胞。
Mol Ther. 2020 Aug 5;28(8):1783-1794. doi: 10.1016/j.ymthe.2020.05.005. Epub 2020 May 16.

引用本文的文献

1
NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers.NSD2抑制剂通过重塑染色质来治疗肺癌和胰腺癌。
Nature. 2025 Aug 6. doi: 10.1038/s41586-025-09299-y.
2
Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy.重塑肿瘤免疫微环境以改善基于 CAR-T 细胞的癌症免疫疗法。
Mol Cancer. 2024 Aug 26;23(1):175. doi: 10.1186/s12943-024-02079-8.
3
Light-Responsive Materials in Droplet Manipulation for Biochemical Applications.用于生化应用的液滴操控中的光响应材料。

本文引用的文献

1
Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence.全基因组 CRISPR 筛选 T 细胞耗竭鉴定出限制 T 细胞持久性的染色质重塑因子。
Cancer Cell. 2022 Jul 11;40(7):768-786.e7. doi: 10.1016/j.ccell.2022.06.001. Epub 2022 Jun 23.
2
Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq.利用全基因组 Perturb-seq 技术绘制富含信息的基因型-表型图谱。
Cell. 2022 Jul 7;185(14):2559-2575.e28. doi: 10.1016/j.cell.2022.05.013. Epub 2022 Jun 9.
3
BCL6-dependent TCF-1 progenitor cells maintain effector and helper CD4 T cell responses to persistent antigen.
Adv Mater. 2025 Jan;37(2):e2313935. doi: 10.1002/adma.202313935. Epub 2024 Mar 1.
4
Clonal tracking in cancer and metastasis.癌症和转移中的克隆追踪。
Cancer Metastasis Rev. 2024 Jun;43(2):639-656. doi: 10.1007/s10555-023-10149-4. Epub 2023 Nov 1.
BCL6 依赖性 TCF-1 祖细胞维持效应器和辅助性 CD4 T 细胞对持续性抗原的应答。
Immunity. 2022 Jul 12;55(7):1200-1215.e6. doi: 10.1016/j.immuni.2022.05.003. Epub 2022 May 27.
4
CRISPR activation and interference screens decode stimulation responses in primary human T cells.CRISPR 激活和干扰筛选解码原代人 T 细胞的刺激反应。
Science. 2022 Feb 4;375(6580):eabj4008. doi: 10.1126/science.abj4008.
5
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.转移性人类癌症中抗肿瘤新生抗原反应性 T 细胞的分子特征。
Science. 2022 Feb 25;375(6583):877-884. doi: 10.1126/science.abl5447. Epub 2022 Feb 3.
6
Decade-long leukaemia remissions with persistence of CD4 CAR T cells.长达十年的白血病缓解期与 CD4 CAR T 细胞的持续存在。
Nature. 2022 Feb;602(7897):503-509. doi: 10.1038/s41586-021-04390-6. Epub 2022 Feb 2.
7
Pan-cancer single-cell landscape of tumor-infiltrating T cells.泛癌种肿瘤浸润 T 细胞单细胞全景分析。
Science. 2021 Dec 17;374(6574):abe6474. doi: 10.1126/science.abe6474.
8
An NK-like CAR T cell transition in CAR T cell dysfunction.嵌合抗原受体 T 细胞功能障碍中的 NK 样 CAR T 细胞转变。
Cell. 2021 Dec 9;184(25):6081-6100.e26. doi: 10.1016/j.cell.2021.11.016. Epub 2021 Dec 2.
9
Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data.通过整合批量和单细胞测序数据来识别表型相关的亚群。
Nat Biotechnol. 2022 Apr;40(4):527-538. doi: 10.1038/s41587-021-01091-3. Epub 2021 Nov 11.
10
Identifying transcriptional programs underlying cancer drug response with TraCe-seq.利用TraCe-seq鉴定癌症药物反应背后的转录程序。
Nat Biotechnol. 2022 Jan;40(1):86-93. doi: 10.1038/s41587-021-01005-3. Epub 2021 Sep 16.